{"id":"https://openalex.org/W2145454199","doi":"https://doi.org/10.2174/1872312808666140317151735","title":"A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs","display_name":"A Proposed Screening Paradigm for Discovery of Covalent Inhibitor Drugs","alternate_titles":[],"publication_year":2014,"publication_date":"2014-03-17","ids":{"openalex":"https://openalex.org/W2145454199","doi":"https://doi.org/10.2174/1872312808666140317151735","mag":"2145454199","pmid":"https://pubmed.ncbi.nlm.nih.gov/24628405"},"language":"en","primary_location":{"id":"doi:10.2174/1872312808666140317151735","doi":"https://doi.org/10.2174/1872312808666140317151735","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1872312808666140317151735","pdf_url":null,"source":{"id":"https://openalex.org/S51092485","display_name":"Drug Metabolism Letters","issn_l":"1872-3128","issn":["1872-3128","1874-0758"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism Letters","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2145454199"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5107791867","display_name":"Mehran Fallah Moghaddam","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mehran Moghaddam","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101596314","display_name":"Yang Tang","orcid":"https://orcid.org/0000-0002-2750-8029","observed_orcids":["https://orcid.org/0000-0002-2750-8029","https://orcid.org/0000-0003-1516-5433"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yang Tang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037914070","display_name":"Zhihong O\u2019Brien","orcid":"https://orcid.org/0009-0001-6800-8338","observed_orcids":["https://orcid.org/0009-0001-6800-8338"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Zhihong O\u2019Brien","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Samantha Richardson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Samantha Richardson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047071829","display_name":"Maria D. Bacolod","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Bacolod","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045613848","display_name":"Prasoon Chaturedi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Prasoon Chaturedi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017812973","display_name":"Julius L. Apuy","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julius Apuy","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5077970617","display_name":"Ashutosh A. Kulkarni","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ashutosh Kulkarni","raw_affiliation_strings":["Department of Drug Metabolism and Pharmacokinetics, Celgene Corporation, 10300 Campus Point Dr, Suite 100, San Diego, CA 92121, USA. mmoghadd@celgene.com"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Drug Metabolism and Pharmacokinetics, Celgene Corporation, 10300 Campus Point Dr, Suite 100, San Diego, CA 92121, USA. mmoghadd@celgene.com","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.8901,"has_fulltext":false,"cited_by_count":19,"citation_normalized_percentile":{"value":0.89209804,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"8","issue":"1","first_page":"19","last_page":"30"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.7529000043869019,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.12870000302791595,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.009600000455975533,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/covalent-inhibitors","display_name":"covalent inhibitors","score":0.9919999837875366},{"id":"https://openalex.org/keywords/adme-properties","display_name":"ADME properties","score":0.6159999966621399},{"id":"https://openalex.org/keywords/drug-screening","display_name":"drug screening","score":0.6480000019073486},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.7039999961853027},{"id":"https://openalex.org/keywords/cytochrome-p450-inhibition","display_name":"cytochrome P450 inhibition","score":0.6930000185966492},{"id":"https://openalex.org/keywords/caco-2-permeability","display_name":"Caco-2 permeability","score":0.7590000033378601},{"id":"https://openalex.org/keywords/protein-binding","display_name":"protein binding","score":0.8669999837875366},{"id":"https://openalex.org/keywords/plasma-clearance","display_name":"plasma clearance","score":0.8119999766349792},{"id":"https://openalex.org/keywords/mass-modification","display_name":"mass modification","score":0.5630000233650208},{"id":"https://openalex.org/keywords/target-occupancy","display_name":"target occupancy","score":0.5879999995231628},{"id":"https://openalex.org/keywords/early-drug-discovery","display_name":"early drug discovery","score":0.45100000500679016}],"concepts":[{"id":"https://openalex.org/C69366308","wikidata":"https://www.wikidata.org/wiki/Q2272286","display_name":"ADME","level":3,"score":0.9505590200424194},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.7927266955375671},{"id":"https://openalex.org/C22979827","wikidata":"https://www.wikidata.org/wiki/Q5137311","display_name":"Cmax","level":3,"score":0.7565627694129944},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.6529687643051147},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.6356587409973145},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.614764928817749},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.4806562662124634},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.47073638439178467},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.23339685797691345},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19191741943359375},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15770304203033447},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.08913061022758484}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D004355","descriptor_name":"Drug Stability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007408","descriptor_name":"Intestinal Absorption","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007413","descriptor_name":"Intestinal Mucosa","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007527","descriptor_name":"Isoenzymes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007700","descriptor_name":"Kinetics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008862","descriptor_name":"Microsomes, Liver","qualifier_ui":"Q000201","qualifier_name":"enzymology","is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010539","descriptor_name":"Permeability","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013379","descriptor_name":"Substrate Specificity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055808","descriptor_name":"Drug Discovery","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D057166","descriptor_name":"High-Throughput Screening Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057188","descriptor_name":"Workflow","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061605","descriptor_name":"Administration, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D065607","descriptor_name":"Cytochrome P-450 Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.2174/1872312808666140317151735","doi":"https://doi.org/10.2174/1872312808666140317151735","is_oa":false,"landing_page_url":"https://doi.org/10.2174/1872312808666140317151735","pdf_url":null,"source":{"id":"https://openalex.org/S51092485","display_name":"Drug Metabolism Letters","issn_l":"1872-3128","issn":["1872-3128","1874-0758"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","norway-1","poland-40"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Metabolism Letters","raw_type":"journal-article"},{"id":"pmid:24628405","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24628405","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug metabolism letters","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308804","display_name":"International Association for Dental Research","ror":"https://ror.org/008vgd385"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2037195365","https://openalex.org/W7128686931","https://openalex.org/W2506064136","https://openalex.org/W1987144475","https://openalex.org/W2070213952","https://openalex.org/W4380301919","https://openalex.org/W2327402333","https://openalex.org/W2951295864","https://openalex.org/W4312519094","https://openalex.org/W2158468919"],"abstract_inverted_index":{"The":[0,62,88,148,171],"in":[1,4,20,31,51,122,198,199,202,212,242,257,278],"vitro":[2,52,200],"and":[3,49,106,125,186,201,237,280,294,305,309],"vivo":[5,203],"preclinical":[6],"ADME":[7,204,209],"properties":[8],"of":[9,28,75,83,115,215,254,267,288,307],"10":[10,136],"clinically":[11],"late":[12],"stage":[13],"or":[14],"marketed":[15],"covalent":[16],"inhibitors":[17],"were":[18,118],"evaluated":[19],"order":[21],"to":[22,60,68,99,143,155,167],"define":[23],"advancement":[24],"criteria":[25],"for":[26,44,54,80,134,252],"discovery":[27],"future":[29],"drugs":[30],"this":[32],"arena.":[33],"Our":[34],"studies":[35],"revealed":[36],"the":[37,47,107,116,135,195,213,245,249,265],"following:":[38],"After":[39],"incubating":[40],"with":[41,78,127,180,244,276,291],"S9":[42],"fractions":[43],"30":[45],"minutes,":[46],"rat":[48,124],"human":[50,126],"stability":[53,64],"these":[55,207],"compounds":[56,117,137,256],"ranged":[57,65,92,138,150,162],"from":[58,66,93,139,151,163,183,190],"1%":[59],"100%.":[61,69],"blood":[63],"30%":[67],"There":[70],"was":[71],"a":[72,176,272],"broad":[73,178],"range":[74,179,197],"CYP":[76],"inhibition":[77,82],"prevalence":[79],"time-dependent":[81],"at":[84,270],"least":[85],"one":[86],"enzyme.":[87],"Caco-2":[89],"permeability":[90],"(A\u2192B)":[91],"negligible":[94],"(0.6":[95],"x":[96,103],"10-6":[97,104],"cm/s)":[98,105],"highly":[100,119],"permeable":[101],"(31":[102],"efflux":[108],"ratio":[109],"also":[110,161,174],"varied":[111],"widely":[112],"(0.2-30).":[113],"Most":[114],"protein":[120],"bound":[121],"both":[123],"binding":[128],"\u2265":[129],"90%.":[130],"Rat":[131],"plasma":[132],"clearance":[133],"slow":[140],"(11":[141],"mL/min/kg)":[142],"very":[144,156,177],"rapid":[145],"(350":[146],"mL/min/kg).":[147],"Vss":[149],"low":[152],"(0.67":[153],"L/kg)":[154],"high":[157],"(115":[158],"L/kg).":[159],"MRT\u2019s":[160],"short":[164],"(0.5":[165],"hr)":[166],"long":[168],"(7.4":[169],"hr).":[170],"oral":[172],"exposures":[173],"showed":[175],"Cmax\u2019s":[181],"ranging":[182,189],"0.01-77":[184],"\u03bcM":[185],"exposure":[187],"levels":[188],"0.03-106":[191],"\u03bcM.hr.":[192],"In":[193,218],"conclusion,":[194],"wide":[196],"data":[205,241],"makes":[206],"particular":[208],"assays":[210,222],"non-discriminatory":[211],"selection":[214],"promising":[216],"compounds.":[217],"our":[219],"opinion,":[220],"non-traditional":[221],"such":[223],"as":[224],"target":[225,228,235,238],"mass":[226],"modification,":[227],"confirmation":[229],"by":[230],"amino":[231],"acid":[232],"sequencing,":[233],"cellular":[234],"occupancy,":[236],"turnover":[239],"rate":[240],"combination":[243],"pharmacokinetic":[246],"profiles":[247],"are":[248],"critical":[250],"considerations":[251],"progression":[253],"irreversible":[255],"early":[258],"discovery.":[259],"Biography:":[260],"Mehran":[261],"Moghaddam,":[262],"PhD,":[263],"is":[264],"head":[266],"Discovery":[268],"DMPK":[269],"Celgene,":[271],"global":[273],"biopharmaceutical":[274],"company":[275],"products":[277],"oncology":[279],"immune-inflammatory":[281],"related":[282],"diseases.":[283],"He":[284],"has":[285],"18":[286],"years":[287],"industrial":[289],"experience":[290],"DuPont,":[292],"Pfizer,":[293],"Celgene.":[295],"His":[296],"expertise":[297],"includes":[298],"animal":[299],"experimentation,":[300],"pharmacokinetics,":[301,317],"metabolism,":[302],"metabolite/catabolite":[303],"identification,":[304],"bioanalysis":[306],"small":[308],"macro-molecules.":[310],"Keywords:":[311],"ADME,":[312],"covalent,":[313],"discovery,":[314],"irreversible,":[315],"mass-modification,":[316],"screening.":[318]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2145454199","counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":4}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
